von Willebrand's disease in Mexico: a pilot study

被引:7
|
作者
Majluf-Cruz, A. [1 ]
Velez-Ruelas, M. A. [2 ]
Gonzalez-Avila, A. I. [3 ]
Garcia-Chavez, J. [4 ]
Berges, A. [5 ]
Lopez-Santiago, N. [6 ]
Monroy-Garcia, R. [1 ]
Moreno-Hernandez, M. [1 ]
Corona-De La Pena, N. [1 ]
Alvarado-Moreno, J. A. [1 ]
Isordia-Salas, I. [1 ]
Hernandez-Juarez, J. [1 ]
机构
[1] Inst Mexicano Seguro Social, UIM Trombosis Hemostasia & Aterogenesis, Mexico City, DF, Mexico
[2] Federac Hematol AC, Mexico City, DF, Mexico
[3] Inst Mexicano Seguro Social, HGR Carlos MacGregor, Dept Hematol, Mexico City, DF, Mexico
[4] UMAE Hosp Especialidades, CMN La Raza, Dept Hematol, Inst Mexicano Seguro Social, Mexico City, DF, Mexico
[5] UMAE Hosp Gen, CMN La Raza, Dept Hematol, Inst Mexicano Seguro Social, Mexico City, DF, Mexico
[6] Inst Nacl Pediat, Dept Hematol, Mexico City, DF, Mexico
关键词
Mexico; prevalence; von Willebrand factor; von Willebrand's disease; HUMAN VONWILLEBRAND-FACTOR; PREVALENCE; DIAGNOSIS;
D O I
10.1111/hae.12016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand's disease (VWD) is the most commonly inherited bleeding disorder. For a long time, it has been said that VWD was absent in some countries due to ethnical differences. Information about the prevalence of VWD in Mexico remains unclear, owing largely to poor awareness and diagnosis of the disease. The aim of this study was to objectively diagnose VWD in a cohort of highly selected Mexican patients with a chronic history of bleeding. Mexican Mestizos were recruited between July 2010 and August 2011. Included were 133 adult and paediatric patients with a high suspicion of VWD. Fifty-three were diagnosed with VWD: 47 (88.7%) with type 1 VWD, four (7.5%) with type 2a VWD and two (3.8%) with type 3 VWD. Mean age for female patients was 19.5years (range 344years) and 18.5years (range 463years) for male patients. Mean age at start of bleeding symptoms was 8.8years (range 161). The most frequent clinical symptoms were epistaxis (84.9%), ecchymosis (79.2%), haematomas (71.7%), gum bleeds (62.3%) and petechia (50.9%). Severe transoperative or postoperative bleeding was found in 17 patients (32.1%). Twenty-six women at childbearing age had a history of abnormal gynaecological bleeding. Our results clearly demonstrate the presence of VWD in Mexican and underscore the importance of a more detailed description of VWD. Efforts to increase the awareness and diagnosis of VWD could help in better identification of patients with bleeding disorders and lead to early, appropriate management with safe and efficacious therapies such as desmopressin and plasma concentrates.
引用
收藏
页码:231 / 235
页数:5
相关论文
共 50 条
  • [21] Von Willebrand Disease in the United States: A Perspective from Wisconsin
    Flood, Veronica H.
    Gill, Joan Cox
    Friedman, Kenneth D.
    Bellissimo, Daniel B.
    Haberichter, Sandra L.
    Montgomery, Robert R.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2011, 37 (05) : 528 - 534
  • [22] Von Willebrand's disease.
    Papayan, LP
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1996, 41 (05): : 5 - 8
  • [23] Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease
    Govorov, Igor
    Ekelund, Lena
    Chaireti, Roza
    Elfvinge, Petra
    Holmstrom, Margareta
    Bremme, Katarina
    Mints, Miriam
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (05) : 1923 - 1929
  • [24] von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
    Sanders, Yvonne V.
    Groeneveld, Dafna
    Meijer, Karina
    Fijnvandraat, Karin
    Cnossen, Marjon H.
    van der Bom, Johanna G.
    Coppens, M.
    de Meris, Joke
    Laros-van Gorkom, Britta A. P.
    Mauser-Bunschoten, Eveline P.
    Leebeek, Frank W. G.
    Eikenboom, Jeroen
    BLOOD, 2015, 125 (19) : 3006 - 3013
  • [25] Utility of thromboelastography for the diagnosis of von Willebrand disease
    Regling, Katherine
    Kakulavarapu, Srikruthi
    Thomas, Ronald
    Hollon, Wendy
    Chitlur, Meera B.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
  • [26] Von Willebrand disease combined with defects in Iran
    Seidizadeh, Omid
    Ahmadinejad, Minoo
    Homayoun, Sanaz
    Mannucci, Pier Mannuccio
    Peyvandi, Flora
    BLOOD TRANSFUSION, 2021, 19 (05) : 428 - 434
  • [27] Update on Molecular Testing in von Willebrand Disease
    Batlle, Javier
    Perez-Rodriguez, Almudena
    Corrales, Irene
    Borras, Nina
    Costa Pinto, Joana
    Fernanda Lopez-Fernandez, Maria
    Vidal, Francisco
    Cid, Ana Rosa
    Bonanad, Santiago
    Parra, Rafael
    Eva Mingot-Castellano, Maria
    Navarro, Nira
    Altisent, Carmen
    Perez-Montes, Rocio
    Marcellini, Shally
    Moreto, Ana
    Herrero, Sonia
    Soto, Inmaculada
    Bernardo-Gutierrez, Angel
    Fernandez Mosteirin, Nuria
    Jimenez-Yuste, Victor
    Alonso, Nieves
    Jacob, Aurora de Andres
    Fontanes, Emilia
    Campos, Rosa
    Jose Paloma, Maria
    Bermejo, Nuria
    Berrueco, Ruben
    Mateo, Jose
    Arribalzaga, Karmele
    Marco, Pascual
    Palomo, Angeles
    Castro Quismondo, Nerea
    Inigo, Belen
    del Mar Nieto, Maria
    Vidal, Rosa
    Paz Martinez, Maria
    Aguinaco, Reyes
    Tenorio, Maria
    Ferreiro, Maria
    Garcia-Frade, Javier
    Maria Rodriguez-Huerta, Ana
    Cuesta, Jorge
    Rodriguez-Gonzalez, Ramon
    Garcia-Candel, Faustino
    Dobon, Manuela
    Aguilar, Carlos
    Maria Bastida, Jose
    Nunez, Ramiro
    Azanzazu Aguirre, Maria
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (07) : 708 - 719
  • [28] Translational medicine advances in von Willebrand disease
    Lillicrap, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 75 - 83
  • [29] Depression and anxiety in persons with Von Willebrand disease
    Roberts, Jonathan C. C.
    Kulkarni, Roshni
    Kouides, Peter A. A.
    Sidonio Jr, Robert F. F.
    Carpenter, Shannon L. L.
    Konkle, Barbara A. A.
    Wu, Joanne
    Ullman, Megan M. M.
    Curtis, Randall
    Baker, Judith R. R.
    Crook, Nicole
    Nichol, Michael B. B.
    HAEMOPHILIA, 2023, 29 (02) : 545 - 554
  • [30] Interaction of factor VIII and von Willebrand factor and the identification of type 2 N von Willebrand disease
    Favaloro, Emmanuel J.
    THROMBOSIS RESEARCH, 2011, 127 (01) : 2 - 3